StockMarketWire.com - OptiBiotix Health said it had entered into a three-year distribution agreement with SilvEXPO for markets in Russia and Kazakhstan.

The agreement would see SilvExpo distribute and commercialise OptiBiotix's own-label CholBiome products, which contain its cholesterol and blood pressure-reducing technology.

'We are pleased to announce this agreement which extends the sales channel of our CholBiome products into Russia and Kazakhstan where cardiovascular disease are the leading cause of morbidity and mortality,' commercial director Per Rehne said.




Story provided by StockMarketWire.com